Dr Carl Edward Ferguson, DO | |
3514 N Power Rd Ste 105, Mesa, AZ 85215-2907 | |
(480) 422-8533 | |
(480) 981-2442 |
Full Name | Dr Carl Edward Ferguson |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 42 Years |
Location | 3514 N Power Rd Ste 105, Mesa, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619068681 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2244 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cardiojost Inc | 2062429913 | 12 |
News Archive
Small particles loaded with medicine could be a future weapon for cancer treatment. A recently-published study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells. And because the particles can be seen in MRI images, they are traceable.
A project developed by a Kingston School of Art London researcher that aims to help people overcome trauma through expressive writing techniques is to be offered to healthcare professionals around the world who are on the front line of the Covid-19 crisis.
Houston Methodist Global Health Care Services, the global subsidiary of Houston Methodist Hospital in Texas, USA, and Istanbul University Hospitals - General Directorate in Istanbul, Turkey, have signed a collaboration agreement in the areas of education and training.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Media outlets continued to look ahead to next week's U.N. Millennium Development Goal (MDG) Summit, with a focus on two of the central themes to be addressed at the meeting - maternal health and poverty.
› Verified 2 days ago
Entity Name | Cardiojost Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023122843 PECOS PAC ID: 2062429913 Enrollment ID: O20060317000050 |
News Archive
Small particles loaded with medicine could be a future weapon for cancer treatment. A recently-published study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells. And because the particles can be seen in MRI images, they are traceable.
A project developed by a Kingston School of Art London researcher that aims to help people overcome trauma through expressive writing techniques is to be offered to healthcare professionals around the world who are on the front line of the Covid-19 crisis.
Houston Methodist Global Health Care Services, the global subsidiary of Houston Methodist Hospital in Texas, USA, and Istanbul University Hospitals - General Directorate in Istanbul, Turkey, have signed a collaboration agreement in the areas of education and training.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Media outlets continued to look ahead to next week's U.N. Millennium Development Goal (MDG) Summit, with a focus on two of the central themes to be addressed at the meeting - maternal health and poverty.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carl Edward Ferguson, DO 5416 E Baseline Rd, Mesa, AZ 85206-4700 Ph: (480) 945-4343 | Dr Carl Edward Ferguson, DO 3514 N Power Rd Ste 105, Mesa, AZ 85215-2907 Ph: (480) 422-8533 |
News Archive
Small particles loaded with medicine could be a future weapon for cancer treatment. A recently-published study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells. And because the particles can be seen in MRI images, they are traceable.
A project developed by a Kingston School of Art London researcher that aims to help people overcome trauma through expressive writing techniques is to be offered to healthcare professionals around the world who are on the front line of the Covid-19 crisis.
Houston Methodist Global Health Care Services, the global subsidiary of Houston Methodist Hospital in Texas, USA, and Istanbul University Hospitals - General Directorate in Istanbul, Turkey, have signed a collaboration agreement in the areas of education and training.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Media outlets continued to look ahead to next week's U.N. Millennium Development Goal (MDG) Summit, with a focus on two of the central themes to be addressed at the meeting - maternal health and poverty.
› Verified 2 days ago
Dr. Jose Rapanan Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10032 E Southern Ave, Mesa, AZ 85209 Phone: 480-351-2850 | |
Jennifer Christine Fendler, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 N Country Club Dr, Mesa, AZ 85201 Phone: 480-601-3528 | |
George Ting, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1111 N Stapley Dr, Mesa, AZ 85203 Phone: 480-464-8500 | |
Dr. Thomas P Porter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1950 S Country Club Dr, Mesa, AZ 85210 Phone: 480-969-1446 Fax: 480-969-9105 | |
Dana S Farris, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10238 E Hampton Ave Ste 506, Mesa, AZ 85209 Phone: 480-834-7546 Fax: 480-833-8313 | |
Nancy Mucha, CNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2843 N 89th St, Mesa, AZ 85207 Phone: 480-396-3482 | |
Ryan Elisabeth Romo, Family Medicine Medicare: Medicare Enrolled Practice Location: 1705 W Main St, Mesa, AZ 85201 Phone: 877-809-5092 |